Lucid Pharma Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg recall — FDA D-0921-2017
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Overview of recall records associated with Lucid Pharma LLC, including dates, categories and classifications where available.
Classification mix: Class II: 1.
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
This page summarizes recall records in which the official source identifies Lucid Pharma LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.